Arvelle Therapeutics

Cerevel Therapeutics

This biopharmaceutical company develops neuroscience medicines for patients with mental and neurological conditions including schizophrenia, Parkinson's disease and epilepsy.

Lario Therapeutics

This company develops precision medicines for patients with severe neurological disorders, including epilepsy and Parkinson’s disease.

Tenacia Biotechnology

This biopharmaceutical company develops and commercialises therapeutics for patients with central nervous system disorders, including epilepsy, bipolar disorder and essential tremor.

Accure Therapeutics

This biopharmaceutical company develops central nervous system medicines to treat patients with conditions such as multiple sclerosis, Parkinson's disease, epilepsy and optic neuritis.

Corlieve Therapeutics

The company develops gene therapies for patients with refractory temporal lobe epilepsy and other severe neurological disorders.

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

Engage Therapeutics

This biopharmaceutical company develops medicines for patients living with severe neurological and autoimmune conditions, including epilepsy, psoriasis and osteoporosis.

EpilepsyGTx

This company develops precision gene therapies for patients with focal refractory epilepsy to provide seizure freedom.